ORBIMED ADVISORS LLC 13D and 13G filings for Turning Point Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-07 4:39 pm Sale | 2021-03-01 | 13D | Turning Point Therapeutics, Inc. TPTX | ORBIMED ADVISORS LLC | 1,743,950 3.600% | -283,600 (-13.99%) | Filing |
| 2020-05-22 4:54 pm Unchanged | 2020-05-21 | 13D | Turning Point Therapeutics, Inc. TPTX | ORBIMED ADVISORS LLC | 2,027,550 4.900% | 0 (Unchanged) | Filing |